Related Experiment Video
Updated: Jun 15, 2025

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
146
Prostate magnetic resonance imaging and the value of experience: An intrareader variability study
Thomas Whish-Wilson1,2, Jo-Lynn Tan1, William Cross3
1Department of Surgery, St Vincent's Hospital Melbourne, 41 Victoria Pde, Fitzroy VIC, Australia.
Asian Journal of Urology
|August 26, 2024
Summary
Experienced radiologists show moderate agreement in prostate MRI (mpMRIp) interpretation over time. While sensitivity decreased, specificity and positive predictive value improved, supporting mpMRIp for prebiopsy screening.
Area of Science:
- Radiology
- Urology
- Oncology
Background:
- Multiparametric magnetic resonance imaging of the prostate (mpMRIp) is crucial for prostate cancer detection.
- Standardized reporting systems like PI-RADS v2 aim to improve consistency in mpMRIp interpretation.
- Understanding intraobserver variability is essential for validating diagnostic accuracy over time.
Purpose of the Study:
- To assess the intraobserver agreement of an experienced genitourinary radiologist in reporting prostate mpMRI scans.
- To evaluate changes in diagnostic performance metrics after a period of increased experience.
Main Methods:
- An experienced radiologist re-reported 100 mpMRIp scans using PI-RADS v2 after gaining significant additional experience (>1000 scans).
- Intraobserver agreement was quantified using Cohen's kappa.
- Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated and compared.
Main Results:
- Moderate intraobserver agreement (Cohen's kappa = 0.55) was observed for lesion identification.
- Re-reading showed a significant increase in specificity (43% to 89%) and PPV (62% to 87%).
- Sensitivity decreased from 94% to 72% (p=0.01), and NPV decreased from 89% to 77%.
Conclusions:
- Intraobserver agreement in mpMRIp reporting using PI-RADS v2 is moderate, even for experienced radiologists.
- Improved specificity and PPV with experience offset reduced sensitivity, reinforcing mpMRIp's role in prebiopsy assessment.
- mpMRIp is validated as a valuable tool for prebiopsy prostate cancer screening.

